News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | US-Iran Talks Near Agreement; Robinhood Plans $1.5B Stock Buyback; PDD Reports Earnings Today (March 25, 2026)2Circle’s European Expansion: Will Adaptable Regulations Release $316B in Stablecoin Transactions?3Bitcoin Remains Steady at $70K as Gold Plummets: Interpreting Market Movements Amid Geopolitical Turmoil
Tapestry, Inc. (TPR) Reached Its Highest Point in a Year—Will the Momentum Last?
101 finance·2026/02/27 15:19
What Insights Analyst Forecasts Provide on Genius Sports Limited (GENI) Q4 Performance Indicators
101 finance·2026/02/27 15:18
Toronto Dominion Bank (The) (TD) Reached a 52-Week Peak, Will the Momentum Persist?
101 finance·2026/02/27 15:18
Gear Up for Dycom Industries (DY) Q4 Results: Analyst Forecasts for Major Performance Indicators
101 finance·2026/02/27 15:18
Crocs: A $54M Bet vs. a $54M Lawsuit – What's Priced In?
101 finance·2026/02/27 15:12
DD's MemCor MBR Selected for Wastewater Treatment Expansion in the UK
101 finance·2026/02/27 15:12
Crypto taxes updated, BTC stuck below $70K: Month in charts
Cointelegraph·2026/02/27 15:12
DNLI Q4 Reports Smaller-Than-Anticipated Loss, Spotlight on Hunter Syndrome Treatment
101 finance·2026/02/27 15:09
Battalion Oil Surges 38% on Strategic Asset Sale – What’s Next for BATL?
101 finance·2026/02/27 15:07
Roku, Inc. (ROKU) is Drawing Interest from Investors: Key Information You Need to Know
101 finance·2026/02/27 15:07
Flash
19:07
Visa will assist banks in enabling stablecoin payments and on-chain settlementVisa will assist banks in enabling stablecoin payments and on-chain settlement on institutional blockchain networks, while ensuring privacy protection. (Decrypt)
19:06
Biopharmaceutical company Corcept Medical (NASDAQ: CORT) recently disclosed that the wholesale acquisition cost for a standard 28-day course of its novel endocrine therapy Lobivorli is $37,900.This pricing strategy provides clear economic parameters for medical payers to assess this breakthrough treatment for Cushing's syndrome. The company emphasized that this price reflects the significant efficacy and innovative value demonstrated by the therapy in clinical studies.
18:50
SpaceX considers IPO to raise $75 billion, valuation may exceed $1.75 trillionGolden Ten Data reported on March 26 that, according to sources cited by foreign media, SpaceX is considering setting a fundraising target of approximately $75 billion for its IPO. The company has already discussed the possibility of raising more than $70 billion with potential investors, both figures far exceeding the previously reported $50 billion target. SpaceX may be seeking a valuation of over $1.75 trillion in the IPO, and is considering a listing in June, though the timing is still subject to change.
News